SeaStar Medical Holding Corporation (ICU)Healthcare | Biotechnology | Denver, United States | NasdaqCM
4.63 USD
+0.43
(10.238%)
⇧
(April 20, 2026, 4 p.m.
EDT)
Short-term: ★☆☆☆☆ | Long-term: ☆☆☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 18, 2026, 11:21 p.m. EDT
High-risk value trap facing delisting threats; the 1-for-10 reverse split and 'bankruptcy' fears in news headlines signal severe distress, negating any temporary price stabilization seen in recent trading. |
| Model | MAE |
|---|---|
| MSTL ✓ | 0.146886 |
| AutoETS | 0.156074 |
| AutoTheta | 0.554936 |
| AutoARIMA | 0.644659 |
Forecast horizon: 45 days | Selected: MSTL
| Forecast Reliability | |
|---|---|
| Score | 19% |
| H-stat | 66.86 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.000 |
| Excess Kurtosis | 0.95 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 5.04 |
| Revenue per Share | 0.595 |
| Market Cap | 18,490,920 |
| Forward P/E | -1.80 |
| Beta | -1.19 |
| Previous Name | LMF Acquisition Opportunities, Inc. |
| Website | https://seastarmedical.com |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.6296 |
| Address1 | 3,513 Brighton Boulevard |
| Address2 | Suite 410 |
| All Time High | 5,500.0 |
| All Time Low | 2.07 |
| Ask | 4.68 |
| Ask Size | 1 |
| Average Daily Volume10 Day | 127,770 |
| Average Daily Volume3 Month | 148,042 |
| Average Volume | 148,042 |
| Average Volume10Days | 127,770 |
| Beta | -1.189 |
| Bid | 4.51 |
| Bid Size | 1 |
| Book Value | 2.709 |
| City | Denver |
| Compensation As Of Epoch Date | 1,735,603,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 4.63 |
| Current Ratio | 3.629 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 4.645 |
| Day Low | 4.0 |
| Debt To Equity | 5.04 |
| Display Name | SeaStar Medical Holding |
| Earnings Call Timestamp End | 1,747,254,600 |
| Earnings Call Timestamp Start | 1,747,254,600 |
| Earnings Timestamp End | 1,755,259,200 |
| Earnings Timestamp Start | 1,754,909,940 |
| Ebitda Margins | 0.0 |
| Enterprise To Revenue | 5.702 |
| Enterprise Value | 7,035,919 |
| Eps Forward | -2.57 |
| Eps Trailing Twelve Months | -5.86 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 2.9532 |
| Fifty Day Average Change | 1.6768 |
| Fifty Day Average Change Percent | 0.56779087 |
| Fifty Two Week Change Percent | -62.96 |
| Fifty Two Week High | 13.4 |
| Fifty Two Week High Change | -8.7699995 |
| Fifty Two Week High Change Percent | -0.6544776 |
| Fifty Two Week Low | 2.07 |
| Fifty Two Week Low Change | 2.5600002 |
| Fifty Two Week Low Change Percent | 1.2367151 |
| Fifty Two Week Range | 2.07 - 13.4 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,616,074,200,000 |
| Float Shares | 3,951,585 |
| Forward Eps | -2.57 |
| Forward P E | -1.8015565 |
| Free Cashflow | -9,391,750 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 17 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.95705 |
| Gross Profits | 1,181,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.02405 |
| Held Percent Institutions | 0.06103 |
| Implied Shares Outstanding | 3,993,719 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,767,571,200 |
| Last Split Factor | 1:10 |
| Long Business Summary | SeaStar Medical Holding Corporation, a commercial-stage medical device company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers the selective cytopheretic device (SCD), which is a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperinflammation; and QUELIMMUNE, an SCD therapy for pediatric patients with acute kidney injury (AKI) due to sepsis. It also develops NEUTRALIZE-AKI, an SCD therapy that is in clinical trials for adult patients with AKI; and other products in various therapeutic areas, including cardiorenal syndrome, hepatorenal syndrome, and myocardial stunning in end-stage renal disease. SeaStar Medical Holding Corporation was founded in 2007 and is headquartered in Denver, Colorado. |
| Long Name | SeaStar Medical Holding Corporation |
| Market | us_market |
| Market Cap | 18,490,920 |
| Market State | PRE |
| Max Age | 86,400 |
| Message Board Id | finmb_111447 |
| Most Recent Quarter | 1,767,139,200 |
| Name Change Date | 2,026-04-20 |
| Net Income To Common | -12,150,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 18,490,918 |
| Number Of Analyst Opinions | 2 |
| Open | 4.17 |
| Operating Cashflow | -13,599,000 |
| Operating Margins | -7.1809497 |
| Payout Ratio | 0.0 |
| Phone | 844 427 8100 |
| Pre Market Change | -0.026000023 |
| Pre Market Change Percent | -0.56204116 |
| Pre Market Price | 4.6 |
| Pre Market Time | 1,776,770,048 |
| Prev Name | LMF Acquisition Opportunities, Inc. |
| Previous Close | 4.2 |
| Price Hint | 4 |
| Price To Book | 1.7091178 |
| Price To Sales Trailing12 Months | 14.984538 |
| Profit Margins | 0.0 |
| Quick Ratio | 3.265 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | 0.4300003 |
| Regular Market Change Percent | 10.238103 |
| Regular Market Day High | 4.645 |
| Regular Market Day Low | 4.0 |
| Regular Market Day Range | 4.0 - 4.645 |
| Regular Market Open | 4.17 |
| Regular Market Previous Close | 4.2 |
| Regular Market Price | 4.63 |
| Regular Market Time | 1,776,715,200 |
| Regular Market Volume | 95,716 |
| Return On Assets | -0.80882 |
| Return On Equity | -2.95154 |
| Revenue Growth | 5.269 |
| Revenue Per Share | 0.595 |
| Sand P52 Week Change | 0.34445214 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 3,993,719 |
| Shares Percent Shares Out | 0.0539 |
| Shares Short | 215,212 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 233,272 |
| Short Name | SeaStar Medical Holding Corpora |
| Short Percent Of Float | 0.0542 |
| Short Ratio | 1.07 |
| Source Interval | 15 |
| State | CO |
| Symbol | ICU |
| Target High Price | 12.0 |
| Target Low Price | 6.0 |
| Target Mean Price | 9.0 |
| Target Median Price | 9.0 |
| Total Cash | 11,980,000 |
| Total Cash Per Share | 3.0 |
| Total Debt | 525,000 |
| Total Revenue | 1,234,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -5.86 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 4.863825 |
| Two Hundred Day Average Change | -0.23382473 |
| Two Hundred Day Average Change Percent | -0.04807425 |
| Type Disp | Equity |
| Volume | 95,716 |
| Website | https://seastarmedical.com |
| Zip | 80,216 |